AACE released clinical guidelines on the diagnosis, management, and surveillance of tumors related to multiple endocrine neoplasia type 1.

Mucus plugs in former smokers with COPD were associated with faster decline in FEV1 compared with no or resolved plugs.

Topline results were announced from two phase 3 trials evaluating itepekimab in former smokers with inadequately controlled COPD.

Remdesivir was associated with a significant survival benefit and reduced risk for rehospitalization among inpatients with COVID-19 infection.

A federal judge ruled that US prisons must allow transgender inmates to get recommended medical care, including hormone therapy.

The CDC updated guidelines to recommend MMR vaccination for all international travelers regardless of destination.

The Trump administration overturned a Biden era interpretation of EMTALA that hospitals provide abortions in emergency scenarios.

An AAAAI report says climate change has affected the prevalence and morbidity of allergic rhinitis, nonallergic rhinitis, and chronic rhinosinusitis.

Prepandemic severe spirometric obstruction, spirometric restriction, and increased emphysema on CT are linked to higher risk for severe COVID-19.

Cancer organizations are urging researchers, oncologists, and other stakeholders to advocate for cancer research.

The FDA has approved Nucala (mepolizumab) for the add-on maintenance treatment of patients with inadequately controlled eosinophilic COPD.

Emphysema subtypes, identified via CT, may be linked to cardiopulmonary subphenotypes that can help to target cardiac care in early COPD.